AINewsnow

Anthropic's Claude Joins 6 Drug Firms Hunting A Cure For Rare Muscle Disease

Anthropic is teaming up with six drug companies, including Bristol Myers Squibb, to use its Claude AI in the hunt for treatments for a rare muscle-wasting disease that strikes children. Key Takeaways Anthropic said it is working with six medicine developers and launched Anthropic Drug Discovery pro…

Read the full story at DEV Community — Machine Learning ↗

Timeline · 1 report

  1. 2026-10-27 22:02 · DEV Community — Machine Learning
    Anthropic's Claude Joins 6 Drug Firms Hunting A Cure For Rare Muscle Disease

More stories

  1. Anthropic reveals plans for blockbuster IPO — Sky News Technology
  2. Anthropic details early drug development work with six partners and says it has acquired Mithril, a one-person company working on muscular dystrophy (Anthropic) — Techmeme
  3. Frontier AI labs say their models refuted the Exponential Time Hypothesis. What does that mean? — TechCrunch AI
  4. Anthropic's IPO filing shows soaring sales and steep losses — France 24 — Artificial Intelligence
  5. How Anthropic ships the #1 LLM in the World safely: Separating the Brain from the Hands — Latent Space
  6. Meta announces $95B offering to fund AI — Semafor Technology
  7. Moonshot apologises after Kimi K3.1 Pro roll-out stumbles as promotional scrutiny widens — South China Morning Post Tech
  8. Anthropic's Claude bypassed a paywall to access Georgia voter data without authorization — Axios AI+

Get the daily brief of stories like this at 6:30 every morning →